Stockreport

Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy

BAYER AG S/ADR  (BAYRY) 
NASDAQ:AMEX Investor Relations: investor.bayer.com
PDF Not intended for UK MediaCollaboration focuses on developing potential best in class siRNA-based treatment for a form of dilated cardiomyopathyBayer to further strengthe [Read more]